Viewing nowDonepezil ODT 5 mg (Donepezil Hydrochloride Monohydrate)
Donepezil Hydrochloride Hydrate 5.22mg
Orally disintegrating Tablet · Prescription medication
Hanmi Pharmaceutical Co., Ltd.

MFDS item code 201002238 · Notified 2010.03.23 · Insurance code 643505550
Treatment of symptoms of Alzheimer-type dementia
This medication is used for the treatment of Alzheimer's type dementia symptoms. It helps improve memory deterioration, cognitive function decline, and difficulties in daily life caused by dementia. It contributes to enhancing cognitive function in patients and improving their quality of life. Regular intake can slow the progression of dementia symptoms.
Adults: Administer 5 mg of donepezil hydrochloride once daily at bedtime. If sleep disturbances such as abnormal dreams, nightmares, or insomnia occur, consider taking this medicine in the morning. Since donepezil concentrations reach steady state 15 days after administration and the incidence of adverse reactions may be affected by the rate of dose escalation, administer the 5 mg dose for 4~6 weeks. After evaluating the clinical response during this period, the dose may be increased to 10 mg. When increasing the dose to 10 mg daily, administer with caution for gastrointestinal adverse reactions. If treatment with this medicine is discontinued, its effects gradually diminish; no rebound effect occurs with abrupt discontinuation. This medicine is an orally disintegrating tablet. Place it on the tongue and allow it to dissolve, then take it with water or without water. Female patients aged 85 years or older with low body weight: Adverse reactions occur more frequently, so careful monitoring is required. Elderly women with low body weight should not exceed 5 mg daily.
Pediatrics: There is no experience with use in children.
This medication should not be given to patients with the genetic disorder phenylketonuria. This is because the artificial sweetener aspartame contained in this medication is metabolized to phenylalanine in the body. This medication should not be used in patients who are allergic to donepezil hydrochloride, piperidine derivatives, or other components of this medication. Additionally, pregnant women, women who may become pregnant, and breastfeeding mothers should not take this medication. Patients with heart disease, especially those with bradycardia or heart conduction disorders, should use this medication with caution. This medication may slow the heartbeat or cause arrhythmia. Patients taking non-steroidal anti-inflammatory drugs or those with a history of peptic ulcers should closely monitor their gastrointestinal condition when taking this medication. This medication may increase gastric acid secretion and enhance gastrointestinal motility, potentially worsening ulcer symptoms. Patients with a history of asthma or chronic obstructive pulmonary disease should also exercise caution when taking this medication. This medication may constrict bronchial muscles and increase mucus secretion, worsening symptoms. Patients with extrapyramidal disorders such as Parkinson's disease should be cautious as this medication may exacerbate symptoms or cause new ones. This medication may cause various adverse reactions. Cardiac symptoms may include syncope, bradycardia, heart block, and myocardial infarction, while gastrointestinal symptoms may include gastric ulcers and gastrointestinal bleeding. Additionally, hepatic dysfunction, cerebrovascular disorders, motor function disorders, and severe muscular adverse symptoms have also been reported. Psychiatric adverse reactions may include hallucinations, anxiety, insomnia, and depression, while neurological symptoms may include dizziness, seizures, and tremors. This medication may affect driving ability and the ability to operate machinery, so caution is necessary while taking it. This drug may interact with various medications. Especially, when used in conjunction with drugs metabolized in the liver, the efficacy may change, so it's important to consult with a doctor or pharmacist. Pregnant or nursing women should preferably avoid this medication, and if necessary, should consult specialists thoroughly. Safety in pediatric patients has not been established, thus it is not used in children. In case of overdose, symptoms such as nausea, vomiting, bradycardia, and respiratory depression may occur, and immediate medical help should be sought. This medication should be taken by dissolving it on the tongue if in oral tablet form, and should be kept out of reach of children. It should also be stored unopened to prevent discoloration from light exposure.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a sealed container to prevent air exposure, ideally at room temperature between 1°C and 30°C. By storing it this way, its efficacy can be maintained and degradation prevented.
White, round orodispersible tablet
30 tablets/box [10 tablets/PTPX3]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowDonepezil Hydrochloride Hydrate 5.22mg
Orally disintegrating Tablet · Prescription medication
Hanmi Pharmaceutical Co., Ltd.

Donepezil Hydrochloride 5mg
Tablet · Prescription medication
HanDoc Co., Ltd.

Donepezil Hydrochloride 10mg
Tablet · Prescription medication
Hanmi Pharmaceutical Co., Ltd.

Donepezil Hydrochloride Hydrate 10.43mg
Tablet · Prescription medication
IYun Pharmaceuticals Co., Ltd.

Donepezil Hydrochloride Hydrate 10.43mg
Tablet · Prescription medication
Yuhan Corporation

Donepezil Hydrochloride Hydrate 10.43mg
Tablet · Prescription medication
Myungmoon Pharmaceutical Co., Ltd.

Donepezil Hydrochloride Hydrate 10.43mg
Tablet · Prescription medication
HK inno.N Co., Ltd.
Donepezil Hydrochloride 10mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.